CC on XNYS, Materials, The Chemours Company, job postings
Measures activity, not value. Not investment advice.
Shares fell 49% in six months, and the 12 month loss was $154M despite 3.0% quarterly revenue growth.
BadShort interest 9.7% of shares, 6.8 days to cover
WatchCapital spending up 24% to $51M last quarter
Written by AI from the data on this page, 22 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, paints and coatings, plastics, transportation, semiconductor, and others. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
expected around 18 Feb 2027 (an estimate: a year ago it reported on 19 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $1.5B, net income $196.0M.
31 Dec 2021RevenueNet incomeNet losstallest bar $1.9B30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$1.5B
$196.0M
30 Jun 2026
$1.6B
-$274.0M
31 Mar 2026
$1.4B
-$29.0M
31 Dec 2025
$1.3B
-$47.0M
30 Sep 2025
$1.5B
$60.0M
30 Jun 2025
$1.6B
-$381.0M
31 Mar 2025
$1.4B
-$4.0M
31 Dec 2024
$1.4B
-$8.0M
30 Sep 2024
$1.5B
-$27.0M
30 Jun 2024
$1.5B
$70.0M
31 Mar 2024
$1.4B
$52.0M
31 Dec 2023
$1.4B
-$18.0M
30 Sep 2023
$1.5B
$20.0M
30 Jun 2023
$1.6B
-$376.0M
31 Mar 2023
$1.5B
$145.0M
31 Dec 2022
$1.3B
-$97.0M
30 Sep 2022
$1.8B
$240.0M
30 Jun 2022
$1.9B
$201.0M
31 Mar 2022
$1.8B
$234.0M
31 Dec 2021
$1.6B
$233.0M
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$5.8B
$5.8B
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+0.1%
-0.3%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
-$154.0M
-$350.0M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
-$1.02
-$2.33
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
15.1%
17.3%
22.0%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
–
–
-2.3%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
-2.6%
-6.0%
1.3%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
-71.8%
1.7%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
$211.0M
-$12.0M
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$698.0M
$613.0M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$3.8B
$4.2B
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
$3.1B
$3.5B
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
24.7
0.81
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$1.03
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
loss
29.8
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
0.28
1.1
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
0.82
1.4
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
10.6
2.5
Dividend yieldiDividends per share declared in the latest fiscal year divided by the share price.
4.7%
2.0%
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
–
No data for this company
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
-4.1%
443 13F filers vs 462
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
87%
130.6M shares held by 13F filers (30 Sep 2026) of 150.5M outstanding (27 Oct 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
9.7%
14.5M shares sold short (30 Oct 2026) of 150.5M outstanding (27 Oct 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
6.8
14.5M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
-2.1%
14.9M shares sold short in the report before, 14.5M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
58%
58% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 51%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
–
We do not track this company's careers site yet.
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
We do not track this company's careers site yet.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
–
No data for this company
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+3.0%
$1.5B vs $1.5B (quarter ended 30 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
+24%
$51.0M vs $41.0M (quarter ended 30 Sep 2026)
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
–
No data for this company
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
$1.5M
4 quarters, $
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
20
20 articles in the last 7 days; its usual week has 3 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
6.7×
20 articles in the last 7 days; its usual week has 3.
Price $10.88 on 20 Nov 2026, +3.8% over 12 months (12-month range $10.48 to $27.94)
Sharp change
8-K and other filings
Lobbying filing
Insider net buying (open market). Insiders bought a net $489K in the last 12 months (the 12 months before: $301K).Revenue per quarter. Revenue $1.5B in the latest quarter, +3.0% on a year earlier.Capital spending per quarter. Capital spending $51.0M in the latest quarter, +24% on a year earlier.Institutional holders (13F filers). 443 13F filers reported holding it in the latest 13F quarter, +11% on a year earlier.Federal obligations. Federal obligations: $0 published in the last 12 months.Lobbying spend. Lobbying spend: $1.5M published in the last 12 months, -24% on the 12 months before.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, workers in warn layoff notices.
Quarter ended 31 Dec 2021: $1.6B, +18% on a year earlier; public on 12 Feb 2022
Quarter ended 31 Mar 2022: $1.8B, +23% on a year earlier; public on 4 May 2022
Quarter ended 30 Jun 2022: $1.9B, +16% on a year earlier; public on 2 Aug 2022
Quarter ended 30 Sep 2022: $1.8B, +5.8% on a year earlier; public on 27 Oct 2022
Quarter ended 31 Dec 2022: $1.3B, -15% on a year earlier; public on 28 Mar 2024
Quarter ended 31 Mar 2023: $1.5B, -13% on a year earlier; public on 29 Apr 2023
Quarter ended 30 Jun 2023: $1.6B, -14% on a year earlier; public on 29 Jul 2023
Quarter ended 30 Sep 2023: $1.5B, -16% on a year earlier; public on 28 Oct 2023
Quarter ended 31 Dec 2023: $1.4B, +1.7% on a year earlier; public on 28 Mar 2024
Quarter ended 31 Mar 2024: $1.4B, -12% on a year earlier; public on 1 May 2024
Quarter ended 30 Jun 2024: $1.5B, -6.4% on a year earlier; public on 2 Aug 2024
Quarter ended 30 Sep 2024: $1.5B, +0.9% on a year earlier; public on 5 Nov 2024
Quarter ended 31 Dec 2024: $1.4B, -0.1% on a year earlier; public on 19 Feb 2025
Quarter ended 31 Mar 2025: $1.4B, +1.3% on a year earlier; public on 7 May 2025
Quarter ended 30 Jun 2025: $1.6B, +5.0% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $1.5B, -0.4% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $1.3B, -2.2% on a year earlier; public on 25 Feb 2026
Quarter ended 31 Mar 2026: $1.4B, +1.0% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $1.6B, -1.5% on a year earlier; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $1.5B, +3.0% on a year earlier; public on 6 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $83.0M, +57% on a year earlier; public on 12 Feb 2022
Quarter ended 31 Mar 2022: $106.0M, +77% on a year earlier; public on 4 May 2022
Quarter ended 30 Jun 2022: $62.0M, -7.5% on a year earlier; public on 2 Aug 2022
Quarter ended 30 Sep 2022: $72.0M, +7.5% on a year earlier; public on 27 Oct 2022
Quarter ended 31 Dec 2022: $67.0M, -19% on a year earlier; public on 11 Feb 2023
Quarter ended 31 Mar 2023: $91.0M, -14% on a year earlier; public on 29 Apr 2023
Quarter ended 30 Jun 2023: $58.0M, -6.5% on a year earlier; public on 29 Jul 2023
Quarter ended 30 Sep 2023: $86.0M, +19% on a year earlier; public on 28 Oct 2023
Quarter ended 31 Dec 2023: $135.0M, +101% on a year earlier; public on 28 Mar 2024
Quarter ended 31 Mar 2024: $102.0M, +12% on a year earlier; public on 1 May 2024
Quarter ended 30 Jun 2024: $73.0M, +26% on a year earlier; public on 2 Aug 2024
Quarter ended 30 Sep 2024: $76.0M, -12% on a year earlier; public on 5 Nov 2024
Quarter ended 31 Dec 2024: $109.0M, -19% on a year earlier; public on 19 Feb 2025
Quarter ended 31 Mar 2025: $84.0M, -18% on a year earlier; public on 7 May 2025
Quarter ended 30 Jun 2025: $43.0M, -41% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $41.0M, -46% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $45.0M, -59% on a year earlier; public on 25 Feb 2026
Quarter ended 31 Mar 2026: $49.0M, -42% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $44.0M, +2.3% on a year earlier; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $51.0M, +24% on a year earlier; public on 6 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 444; public on 14 Feb 2022
31 Mar 2022 report: 451; public on 16 May 2022
30 Jun 2022 report: 477; public on 15 Aug 2022
30 Sep 2022 report: 437; public on 14 Nov 2022
31 Dec 2022 report: 430; public on 14 Feb 2023
31 Mar 2023 report: 445; public on 15 May 2023
30 Jun 2023 report: 425; public on 14 Aug 2023
30 Sep 2023 report: 412; public on 14 Nov 2023
31 Dec 2023 report: 433; public on 14 Feb 2024
31 Mar 2024 report: 411; public on 15 May 2024
30 Jun 2024 report: 410; public on 14 Aug 2024
30 Sep 2024 report: 395; public on 14 Nov 2024
31 Dec 2024 report: 426; public on 14 Feb 2025
31 Mar 2025 report: 401; public on 15 May 2025
30 Jun 2025 report: 417; public on 14 Aug 2025
30 Sep 2025 report: 398; public on 14 Nov 2025
31 Dec 2025 report: 411; public on 17 Feb 2026
31 Mar 2026 report: 436; public on 15 May 2026
30 Jun 2026 report: 462; public on 14 Aug 2026
30 Sep 2026 report: 443; public on 16 Nov 2026
Federal obligations
Month from 1 Sep 2022: $0 published
Lobbying spend
Quarter from 1 Jan 2022: $270K published
Quarter from 1 Apr 2022: $340K published
Quarter from 1 Jul 2022: $250K published
Quarter from 1 Oct 2022: $280K published
Quarter from 1 Jan 2023: $320K published
Quarter from 1 Apr 2023: $340K published
Quarter from 1 Jul 2023: $280K published
Quarter from 1 Oct 2023: $310K published
Quarter from 1 Jan 2024: $260K published
Quarter from 1 Apr 2024: $340K published
Quarter from 1 Jul 2024: $500K published
Quarter from 1 Oct 2024: $460K published
Quarter from 1 Jan 2025: $320K published
Quarter from 1 Apr 2025: $530K published
Quarter from 1 Jul 2025: $760K published
Quarter from 1 Oct 2025: $340K published
Quarter from 1 Jan 2026: $300K published
Quarter from 1 Apr 2026: $510K published
Quarter from 1 Jul 2026: $340K published
Quarter from 1 Oct 2026: $330K published
What is unusual now
Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $81K (13 Aug 2026), 3.3× its normal reading; higher than 79% of its own history.
Clustered insider buying: had 5 insiders buy $408K of its shares on the open market within 30 days (5 filings) Public on 12 Aug 2026.
Revenue per quarter: Revenue $1.5B in the latest quarter, +3.0% on a year earlier.
Reported lobbying spend: $330K in Q3 2026, $340K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.
Date
Change
Lobbying firm
Issue
Source
1 Jul 2023
New
Bose Public Affairs Groupfor The Chemours Company
Issues relating to a secure domestic supply of critical chemicals and materialsCHM, Environment
Issues related to PFAS, GHG emissions standards and mobile air-conditioning; PFAS legislative proposals; Issues related to clean energy tax credits, environmental clean up funding.; Issues related to PFAS, GHG emissions standards and mobile air-conditioning.; Issues related to PFAS, clean energy R&D.; Issues related to clean energy tax credits, environmental clean up funding.Environment, CHM, Defense, Taxation
Two or more unrelated kinds of records unusual within 30 days
21 Apr 2025confirmed
Confirmed across sources Institutional holdings and Lobbying and Short interest and volume
Chemours(CC): lobbying on a new issue; it also saw 69 13F filers open a new position in the quarter ended 30 Jun 2025, 1.3× the same quarter last year; and it had 18.2M shares sold short in the 15 Aug 2025 report, 2.9× the same report last year. Three unrelated kinds of activity within 140 days.
Short interest and volume: Short interest spike, became public on 10 Apr 2025
Lobbying: Lobbying on a new issue, became public on 21 Apr 2025
Short interest and volume: Short interest spike, became public on 26 Apr 2025
Short interest and volume: Short interest spike, became public on 10 May 2025
Short interest and volume: Short interest spike, became public on 28 May 2025
Short interest and volume: Short interest spike, became public on 11 Jun 2025
Short interest and volume: Short interest spike, became public on 26 Jun 2025
Short interest and volume: Short interest spike, became public on 25 Jul 2025
Short interest and volume: Short interest spike, became public on 12 Aug 2025
Institutional holdings: Many funds opening a new position, became public on 14 Aug 2025
Short interest and volume: Short interest spike, became public on 27 Aug 2025
The quarter ended 30 Jun 2025 against the 8 quarters before it.
this quarterearliernormal: 51See the evidence (11 changes)
Short interest and volume: Short interest spike became public on 10 Apr 2025
Chemours had 12.9M shares sold short in the 31 Mar 2025 report, 2.6× the same report last year.
This period
12.9M (the 31 Mar 2025 report)
Normal report (median of 24 earlier)
7.2M
Typical spread (median absolute deviation)
880K
How far from its usual level
+4.3
Same report last year
4.9M
History used
2,649 days
the 31 Mar 2025 report24 earlier reportsnormal: 7.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Lobbying: Lobbying on a new issue became public on 21 Apr 2025
Chemours lobbying on a new issue.
New
['CPI']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
11559787
Short interest and volume: Short interest spike became public on 26 Apr 2025
Chemours had 13.2M shares sold short in the 15 Apr 2025 report, 2.5× the same report last year.
This period
13.2M (the 15 Apr 2025 report)
Normal report (median of 24 earlier)
7.3M
Typical spread (median absolute deviation)
925K
How far from its usual level
+4.3
Same report last year
5.3M
History used
2,664 days
the 15 Apr 2025 report24 earlier reportsnormal: 7.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 10 May 2025
Chemours had 12.7M shares sold short in the 30 Apr 2025 report, 2.2× the same report last year.
This period
12.7M (the 30 Apr 2025 report)
Normal report (median of 24 earlier)
7.3M
Typical spread (median absolute deviation)
932K
How far from its usual level
+4.0
Same report last year
5.7M
History used
2,679 days
the 30 Apr 2025 report24 earlier reportsnormal: 7.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 28 May 2025
Chemours had 13.3M shares sold short in the 15 May 2025 report, 2.3× the same report last year.
This period
13.3M (the 15 May 2025 report)
Normal report (median of 24 earlier)
7.3M
Typical spread (median absolute deviation)
942K
How far from its usual level
+4.3
Same report last year
5.9M
History used
2,694 days
the 15 May 2025 report24 earlier reportsnormal: 7.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 11 Jun 2025
Chemours had 12.7M shares sold short in the 30 May 2025 report, 2.4× the same report last year.
This period
12.7M (the 30 May 2025 report)
Normal report (median of 24 earlier)
7.3M
Typical spread (median absolute deviation)
957K
How far from its usual level
+3.8
Same report last year
5.4M
History used
2,709 days
the 30 May 2025 report24 earlier reportsnormal: 7.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 26 Jun 2025
Chemours had 14.3M shares sold short in the 13 Jun 2025 report, 2.6× the same report last year.
This period
14.3M (the 13 Jun 2025 report)
Normal report (median of 24 earlier)
7.4M
Typical spread (median absolute deviation)
1.0M
How far from its usual level
+4.7
Same report last year
5.5M
History used
2,723 days
the 13 Jun 2025 report24 earlier reportsnormal: 7.4M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 25 Jul 2025
Chemours had 16.0M shares sold short in the 15 Jul 2025 report, 3.2× the same report last year.
This period
16.0M (the 15 Jul 2025 report)
Normal report (median of 24 earlier)
7.7M
Typical spread (median absolute deviation)
1.2M
How far from its usual level
+4.8
Same report last year
5.1M
History used
2,755 days
the 15 Jul 2025 report24 earlier reportsnormal: 7.7M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 12 Aug 2025
Chemours had 14.9M shares sold short in the 31 Jul 2025 report, 2.9× the same report last year.
This period
14.9M (the 31 Jul 2025 report)
Normal report (median of 24 earlier)
7.8M
Typical spread (median absolute deviation)
1.2M
How far from its usual level
+4.1
Same report last year
5.2M
History used
2,771 days
the 31 Jul 2025 report24 earlier reportsnormal: 7.8M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Institutional holdings: Many funds opening a new position became public on 14 Aug 2025
Chemours saw 69 13F filers open a new position in the quarter ended 30 Jun 2025, 1.3× the same quarter last year.
This period
69 (the quarter ended 30 Jun 2025)
Normal quarter (median of 8 earlier)
51
Typical spread (median absolute deviation)
3
How far from its usual level
+3.5
Same quarter last year
53
History used
3,653 days
the quarter ended 30 Jun 20258 earlier quartersnormal: 51
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Short interest and volume: Short interest spike became public on 27 Aug 2025
Chemours had 18.2M shares sold short in the 15 Aug 2025 report, 2.9× the same report last year.
This period
18.2M (the 15 Aug 2025 report)
Normal report (median of 24 earlier)
7.9M
Typical spread (median absolute deviation)
1.2M
How far from its usual level
+5.9
Same report last year
6.2M
History used
2,786 days
the 15 Aug 2025 report24 earlier reportsnormal: 7.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
10 May 2022confirmed
Confirmed across sources Filings + Financials and Lobbying
Chemours(CC): lobbying on a new issue, while it spent $106.0M on capital projects in the quarter ended 31 Mar 2022, 1.8× the same quarter last year. Two unrelated kinds of activity within 20 days.
Lobbying: Lobbying on a new issue, became public on 20 Apr 2022
Financials: Quarterly capital spending jump, became public on 10 May 2022
The quarter ended 31 Mar 2022 against the 8 quarters before it.
this quarterearliernormal: $64.0MSee the evidence (2 changes)
Lobbying: Lobbying on a new issue became public on 20 Apr 2022
Chemours lobbying on a new issue.
New
['MAN']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
12632182
Financials: Quarterly capital spending jump became public on 10 May 2022
Chemours spent $106.0M on capital projects in the quarter ended 31 Mar 2022, 1.8× the same quarter last year.
This period
$106.0M (the quarter ended 31 Mar 2022)
Normal quarter (median of 8 earlier)
$64.0M
Typical spread (median absolute deviation)
$7.5M
How far from its usual level
+3.8
Same quarter last year
$60.0M
History used
2,739 days
the quarter ended 31 Mar 20228 earlier quartersnormal: $64.0M
Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
21 May 2019confirmed
Confirmed across sources Insiders and Lobbying and Short interest and volume
Chemours(CC): reported $420K of lobbying spend for the quarter ended 31 Mar 2019, 2.1× the same quarter last year; it also had 3 insiders buy $295K of its shares on the open market within 30 days (3 filings); and it had 8.0M shares sold short in the 15 May 2019 report, 2.6× the same report last year. Three unrelated kinds of activity within 86 days.
Lobbying: Lobbying spend jump, became public on 22 Apr 2019
Insiders: Clustered insider buying, became public on 21 May 2019
Short interest and volume: Short interest spike, became public on 25 May 2019
Short interest and volume: Short interest spike, became public on 12 Jun 2019
Short interest and volume: Short interest spike, became public on 26 Jun 2019
Lobbying: Lobbying on a new issue, became public on 19 Jul 2019
The quarter ended 31 Mar 2019 against the 8 quarters before it.
this quarterearliernormal: $125KSee the evidence (6 changes)
Lobbying: Lobbying spend jump became public on 22 Apr 2019
Chemours reported $420K of lobbying spend for the quarter ended 31 Mar 2019, 2.1× the same quarter last year.
This period
$420K (the quarter ended 31 Mar 2019)
Normal quarter (median of 8 earlier)
$125K
Typical spread (median absolute deviation)
$25K
How far from its usual level
+8.0
Same quarter last year
$200K
History used
1,278 days
the quarter ended 31 Mar 20198 earlier quartersnormal: $125K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.
Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.
Short interest and volume: Short interest spike became public on 25 May 2019
Chemours had 8.0M shares sold short in the 15 May 2019 report, 2.6× the same report last year.
This period
8.0M (the 15 May 2019 report)
Normal report (median of 24 earlier)
4.2M
Typical spread (median absolute deviation)
532K
How far from its usual level
+4.8
Same report last year
3.1M
History used
502 days
the 15 May 2019 report24 earlier reportsnormal: 4.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 12 Jun 2019
Chemours had 7.4M shares sold short in the 31 May 2019 report, 2.2× the same report last year.
This period
7.4M (the 31 May 2019 report)
Normal report (median of 24 earlier)
4.3M
Typical spread (median absolute deviation)
527K
How far from its usual level
+3.9
Same report last year
3.4M
History used
518 days
the 31 May 2019 report24 earlier reportsnormal: 4.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 26 Jun 2019
Chemours had 8.1M shares sold short in the 14 Jun 2019 report, 1.9× the same report last year.
This period
8.1M (the 14 Jun 2019 report)
Normal report (median of 24 earlier)
4.4M
Typical spread (median absolute deviation)
598K
How far from its usual level
+4.1
Same report last year
4.1M
History used
532 days
the 14 Jun 2019 report24 earlier reportsnormal: 4.4M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Lobbying: Lobbying on a new issue became public on 19 Jul 2019
Chemours lobbying on a new issue.
New
['DEF']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
12653282
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
Timeline
Changes and notable records, by the date each became public
18 Nov 2026Filings change
filed a director or officer change: SVP, General Counsel & Corporate Secretary Kristine M. Wellman to retire; Amy M. Rocklin succeeds her Jan 4, 2027.
Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.
Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.
had 18.2M shares sold short in the 15 Aug 2025 report, 2.9× the same report last year.
Same report last year: 6.2M; its normal report is 7.9M.
See the evidence
This period
18.2M (the 15 Aug 2025 report)
Normal report (median of 24 earlier)
7.9M
Typical spread (median absolute deviation)
1.2M
How far from its usual level
+5.9
Same report last year
6.2M
History used
2,786 days
the 15 Aug 2025 report24 earlier reportsnormal: 7.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
saw 69 13F filers open a new position in the quarter ended 30 Jun 2025, 1.3× the same quarter last year.
Same quarter last year: 53; its normal quarter is 51.
See the evidence
This period
69 (the quarter ended 30 Jun 2025)
Normal quarter (median of 8 earlier)
51
Typical spread (median absolute deviation)
3
How far from its usual level
+3.5
Same quarter last year
53
History used
3,653 days
the quarter ended 30 Jun 20258 earlier quartersnormal: 51
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
had 14.9M shares sold short in the 31 Jul 2025 report, 2.9× the same report last year.
Same report last year: 5.2M; its normal report is 7.8M.
See the evidence
This period
14.9M (the 31 Jul 2025 report)
Normal report (median of 24 earlier)
7.8M
Typical spread (median absolute deviation)
1.2M
How far from its usual level
+4.1
Same report last year
5.2M
History used
2,771 days
the 31 Jul 2025 report24 earlier reportsnormal: 7.8M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 16.0M shares sold short in the 15 Jul 2025 report, 3.2× the same report last year.
Same report last year: 5.1M; its normal report is 7.7M.
See the evidence
This period
16.0M (the 15 Jul 2025 report)
Normal report (median of 24 earlier)
7.7M
Typical spread (median absolute deviation)
1.2M
How far from its usual level
+4.8
Same report last year
5.1M
History used
2,755 days
the 15 Jul 2025 report24 earlier reportsnormal: 7.7M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 14.3M shares sold short in the 13 Jun 2025 report, 2.6× the same report last year.
Same report last year: 5.5M; its normal report is 7.4M.
See the evidence
This period
14.3M (the 13 Jun 2025 report)
Normal report (median of 24 earlier)
7.4M
Typical spread (median absolute deviation)
1.0M
How far from its usual level
+4.7
Same report last year
5.5M
History used
2,723 days
the 13 Jun 2025 report24 earlier reportsnormal: 7.4M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 12.7M shares sold short in the 30 May 2025 report, 2.4× the same report last year.
Same report last year: 5.4M; its normal report is 7.3M.
See the evidence
This period
12.7M (the 30 May 2025 report)
Normal report (median of 24 earlier)
7.3M
Typical spread (median absolute deviation)
957K
How far from its usual level
+3.8
Same report last year
5.4M
History used
2,709 days
the 30 May 2025 report24 earlier reportsnormal: 7.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 13.3M shares sold short in the 15 May 2025 report, 2.3× the same report last year.
Same report last year: 5.9M; its normal report is 7.3M.
See the evidence
This period
13.3M (the 15 May 2025 report)
Normal report (median of 24 earlier)
7.3M
Typical spread (median absolute deviation)
942K
How far from its usual level
+4.3
Same report last year
5.9M
History used
2,694 days
the 15 May 2025 report24 earlier reportsnormal: 7.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 12.7M shares sold short in the 30 Apr 2025 report, 2.2× the same report last year.
Same report last year: 5.7M; its normal report is 7.3M.
See the evidence
This period
12.7M (the 30 Apr 2025 report)
Normal report (median of 24 earlier)
7.3M
Typical spread (median absolute deviation)
932K
How far from its usual level
+4.0
Same report last year
5.7M
History used
2,679 days
the 30 Apr 2025 report24 earlier reportsnormal: 7.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 13.2M shares sold short in the 15 Apr 2025 report, 2.5× the same report last year.
Same report last year: 5.3M; its normal report is 7.3M.
See the evidence
This period
13.2M (the 15 Apr 2025 report)
Normal report (median of 24 earlier)
7.3M
Typical spread (median absolute deviation)
925K
How far from its usual level
+4.3
Same report last year
5.3M
History used
2,664 days
the 15 Apr 2025 report24 earlier reportsnormal: 7.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
lobbying on a new issue; it also saw 69 13F filers open a new position in the quarter ended 30 Jun 2025, 1.3× the same quarter last year; and it had 18.2M shares sold short in the 15 Aug 2025 report, 2.9× the same report last year. Three unrelated kinds of activity within 140 days.
See the evidence (11 changes)
Short interest and volume: Short interest spike became public on 10 Apr 2025
Chemours had 12.9M shares sold short in the 31 Mar 2025 report, 2.6× the same report last year.
This period
12.9M (the 31 Mar 2025 report)
Normal report (median of 24 earlier)
7.2M
Typical spread (median absolute deviation)
880K
How far from its usual level
+4.3
Same report last year
4.9M
History used
2,649 days
the 31 Mar 2025 report24 earlier reportsnormal: 7.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Lobbying: Lobbying on a new issue became public on 21 Apr 2025
Chemours lobbying on a new issue.
New
['CPI']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
11559787
Short interest and volume: Short interest spike became public on 26 Apr 2025
Chemours had 13.2M shares sold short in the 15 Apr 2025 report, 2.5× the same report last year.
This period
13.2M (the 15 Apr 2025 report)
Normal report (median of 24 earlier)
7.3M
Typical spread (median absolute deviation)
925K
How far from its usual level
+4.3
Same report last year
5.3M
History used
2,664 days
the 15 Apr 2025 report24 earlier reportsnormal: 7.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 10 May 2025
Chemours had 12.7M shares sold short in the 30 Apr 2025 report, 2.2× the same report last year.
This period
12.7M (the 30 Apr 2025 report)
Normal report (median of 24 earlier)
7.3M
Typical spread (median absolute deviation)
932K
How far from its usual level
+4.0
Same report last year
5.7M
History used
2,679 days
the 30 Apr 2025 report24 earlier reportsnormal: 7.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 28 May 2025
Chemours had 13.3M shares sold short in the 15 May 2025 report, 2.3× the same report last year.
This period
13.3M (the 15 May 2025 report)
Normal report (median of 24 earlier)
7.3M
Typical spread (median absolute deviation)
942K
How far from its usual level
+4.3
Same report last year
5.9M
History used
2,694 days
the 15 May 2025 report24 earlier reportsnormal: 7.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 11 Jun 2025
Chemours had 12.7M shares sold short in the 30 May 2025 report, 2.4× the same report last year.
This period
12.7M (the 30 May 2025 report)
Normal report (median of 24 earlier)
7.3M
Typical spread (median absolute deviation)
957K
How far from its usual level
+3.8
Same report last year
5.4M
History used
2,709 days
the 30 May 2025 report24 earlier reportsnormal: 7.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 26 Jun 2025
Chemours had 14.3M shares sold short in the 13 Jun 2025 report, 2.6× the same report last year.
This period
14.3M (the 13 Jun 2025 report)
Normal report (median of 24 earlier)
7.4M
Typical spread (median absolute deviation)
1.0M
How far from its usual level
+4.7
Same report last year
5.5M
History used
2,723 days
the 13 Jun 2025 report24 earlier reportsnormal: 7.4M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 25 Jul 2025
Chemours had 16.0M shares sold short in the 15 Jul 2025 report, 3.2× the same report last year.
This period
16.0M (the 15 Jul 2025 report)
Normal report (median of 24 earlier)
7.7M
Typical spread (median absolute deviation)
1.2M
How far from its usual level
+4.8
Same report last year
5.1M
History used
2,755 days
the 15 Jul 2025 report24 earlier reportsnormal: 7.7M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 12 Aug 2025
Chemours had 14.9M shares sold short in the 31 Jul 2025 report, 2.9× the same report last year.
This period
14.9M (the 31 Jul 2025 report)
Normal report (median of 24 earlier)
7.8M
Typical spread (median absolute deviation)
1.2M
How far from its usual level
+4.1
Same report last year
5.2M
History used
2,771 days
the 31 Jul 2025 report24 earlier reportsnormal: 7.8M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Institutional holdings: Many funds opening a new position became public on 14 Aug 2025
Chemours saw 69 13F filers open a new position in the quarter ended 30 Jun 2025, 1.3× the same quarter last year.
This period
69 (the quarter ended 30 Jun 2025)
Normal quarter (median of 8 earlier)
51
Typical spread (median absolute deviation)
3
How far from its usual level
+3.5
Same quarter last year
53
History used
3,653 days
the quarter ended 30 Jun 20258 earlier quartersnormal: 51
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Short interest and volume: Short interest spike became public on 27 Aug 2025
Chemours had 18.2M shares sold short in the 15 Aug 2025 report, 2.9× the same report last year.
This period
18.2M (the 15 Aug 2025 report)
Normal report (median of 24 earlier)
7.9M
Typical spread (median absolute deviation)
1.2M
How far from its usual level
+5.9
Same report last year
6.2M
History used
2,786 days
the 15 Aug 2025 report24 earlier reportsnormal: 7.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
21 Apr 2025Lobbying change
lobbying on a new issue.
See the evidence
New
['CPI']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
11559787
10 Apr 2025Short interest and volume change
had 12.9M shares sold short in the 31 Mar 2025 report, 2.6× the same report last year.
Same report last year: 4.9M; its normal report is 7.2M.
See the evidence
This period
12.9M (the 31 Mar 2025 report)
Normal report (median of 24 earlier)
7.2M
Typical spread (median absolute deviation)
880K
How far from its usual level
+4.3
Same report last year
4.9M
History used
2,649 days
the 31 Mar 2025 report24 earlier reportsnormal: 7.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 7.7M shares sold short in the 31 Oct 2024 report, 1.3× the same report last year.
Same report last year: 5.8M; its normal report is 5.3M.
See the evidence
This period
7.7M (the 31 Oct 2024 report)
Normal report (median of 24 earlier)
5.3M
Typical spread (median absolute deviation)
425K
How far from its usual level
+3.9
Same report last year
5.8M
History used
2,498 days
the 31 Oct 2024 report24 earlier reportsnormal: 5.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 8.0M shares sold short in the 15 Oct 2024 report, 1.5× the same report last year.
Same report last year: 5.4M; its normal report is 5.3M.
See the evidence
This period
8.0M (the 15 Oct 2024 report)
Normal report (median of 24 earlier)
5.3M
Typical spread (median absolute deviation)
395K
How far from its usual level
+4.6
Same report last year
5.4M
History used
2,482 days
the 15 Oct 2024 report24 earlier reportsnormal: 5.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 7.8M shares sold short in the 30 Sep 2024 report, 1.6× the same report last year.
Same report last year: 5.0M; its normal report is 5.2M.
See the evidence
This period
7.8M (the 30 Sep 2024 report)
Normal report (median of 24 earlier)
5.2M
Typical spread (median absolute deviation)
302K
How far from its usual level
+5.0
Same report last year
5.0M
History used
2,467 days
the 30 Sep 2024 report24 earlier reportsnormal: 5.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 7.3M shares sold short in the 13 Sep 2024 report, 1.5× the same report last year.
Same report last year: 5.0M; its normal report is 5.2M.
See the evidence
This period
7.3M (the 13 Sep 2024 report)
Normal report (median of 24 earlier)
5.2M
Typical spread (median absolute deviation)
266K
How far from its usual level
+4.1
Same report last year
5.0M
History used
2,450 days
the 13 Sep 2024 report24 earlier reportsnormal: 5.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Showing the newest 40 of 139 entries; narrow the window or the kind of data to see older ones.
Not listed: 214 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0001627223
Ticker
CC
Domain
chemours.com
Employer name
The Chemours Company FC, LLC (1 unverified)
Fein
46-5626518 (1 unverified)
Hq location
DE|WILMINGTON|19801 (1 unverified)
Lobbying client
chemours
Name
2463297 Ontario Limited, Chemours Belgium BVBA, Chemours Deutschland GmbH, Chemours France SAS and 49 more
Uei
HKN1HTXZNYB3
Wikidata
Q20630716
Wikipedia
Chemours
DOL H-1B labor condition applications and PERM certifications4 data points9 Mar 2026 to 15 Jun 2026
Federal lobbying disclosures (LDA)13 records, 137 data points1 Apr 2015 to 30 Sep 2026
SEC Form 13F institutional holdings414 data points30 Jun 2015 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)203 records23 Feb 2016 to 18 Nov 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)883 data points31 Dec 2012 to 27 Oct 2026
SEC Form 4 insider transactions88 records, 224 data points12 Feb 2016 to 13 Aug 2026
FINRA short interest (twice monthly)636 data points29 Dec 2017 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
USASpending.gov federal awards3 data points5 Aug 2022 to 5 Aug 2022
Wikipedia pageviews2882 data points1 Jan 2019 to 21 Nov 2026